drugset / Trial / NCT01539655

Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib

NCT01539655

Phase 1 Completed 34 enrolled Sanofi
RandomizedCrossoverOpen-labelBasic science

Summary

Study in healthy volunteers to assess effect of omeprazole and ranitidine on the pharmacokinetics of vandetanib

Timeline

Start
2012-02
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 40 mg Oral
Subject Ranitidine Unknown 150 mg Oral
Subject Vandetanib Small molecule 300 mg Oral